Catalent · 6 hours ago
Cost Accountant
Catalent is a rapidly growing manufacturer of dietary supplements in a soft chew format. The Cost Accountant will proactively participate in the Finance Department’s daily production review and analysis of all costs for the manufacturing site.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Review and entry of daily production and consumption records
Perform finance verification of monthly raw material, WIP, and finished good inventory cycle counts. Audit and maintain the cycle count documentation from all cycle counts, ensuring its accuracy and completeness
Ensure the site maintains compliance with counting frequency and completeness requirements
Monitor inventories and facilitates the paperwork approval, tracking, and filing process to maintain accuracy
Analyze data for discrepancies in manufactured product costs, by reviewing the manufacturing variances and identifying any discrepancies in routings or bills of materials
Assist in the analysis and roll of standard costs as necessary. Ensure all active Raw Materials and Intermediate items have accurate standard costs
Ensure integrity of standard costs and item attributes that impact costing or standard accounting flows
Assist in annual budget process with standard cost rate development
Other duties as assigned
Qualification
Required
Bachelor's degree in Accounting or a related field of study
Minimum three years of experience in Accounting or Manufacturing
Individual may be required to sit, stand, walk regularly and occasionally lift 0-15 pounds
Preferred
Advanced proficiency with various ERP systems, Sage or JDE
Benefits
152 hours of PTO + 8 paid holidays
Generous 401K match
Medical, dental and vision benefits effective day one of employment
Tuition Reimbursement
WellHub - program to promote overall physical wellness
Company
Catalent
Catalent - Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial stage formulation and manufacturing. It is a sub-organization of Catalent Pharma Solutions.
Funding
Current Stage
Late StageTotal Funding
unknown2021-01-06Acquired
Leadership Team
Recent News
2026-01-22
Company data provided by crunchbase